SAFIR Project: A Multicenter Initiative Advancing AI-Driven Cardiovascular Risk Stratification
Paris, 30.06.2025 — Imageens and Womia, a HealthTech startup dedicated to expanding access to cardiovascular prevention in emerging markets, are proud to announce the launch of SAFIR — a multicenter pilot deployment of CardioInspect, a next-generation platform for advanced cardiovascular risk stratification.
This joint initiative brings together leading international institutions to evaluate CardioInspect’s clinical performance and integration into real-world, multi-site environments. The goal is to demonstrate how artificial intelligence can transform routine medical imaging into a powerful, predictive tool for proactive cardiovascular care—particularly for populations in the Middle East and Africa (MEA).
“This initiative reflects our shared commitment to making precision prevention a clinical reality,” said Dr. Sabrine Aidi-Knani, CEO of Womia. “By working alongside leading academic and clinical institutions, we’re validating the impact of CardioInspect across geographies and patient populations.”
“At Imageens, we’re excited to see our imaging-based biomarkers come to life in clinical workflows across MEA,” added Dr. Anas Dogui, CEO of Imageens. “This partnership with Womia is a testament to the power of cross-border collaboration in driving innovation where it’s needed most.”
The SAFIR pilot includes multiple leading public and private healthcare centers across Tunisia and the UAE, reflecting the growing regional momentum toward AI-enabled cardiovascular prevention.
Cardiovascular disease remains the leading cause of death globally, with an especially heavy burden in the MEA region. SAFIR addresses the urgent need for scalable, non-invasive solutions that enable earlier detection and more targeted prevention.
About Womia
Womia is a HealthTech startup focused on democratizing access to AI-driven cardiovascular prevention. With deep scientific roots and strong clinical partnerships, Womia aims to make high-quality, proactive care available to underserved populations across emerging markets, starting in the MEA region.
About Imageens
Imageens is a Paris-based HealthTech company founded in 2017, focused on the prevention and early diagnosis of cardiovascular diseases (CVD).
